Academic Journal
MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression.
| Title: | MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. |
|---|---|
| Authors: | Knight, JRP, Alexandrou, C, Skalka, GL, Vlahov, N, Pennel, K, Officer, L, Teodosio, A, Kanellos, G, Gay, DM, May-Wilson, S, Smith, EM, Najumudeen, AK, Gilroy, K, Ridgway, RA, Flanagan, DJ, Smith, RCL, McDonald, L, MacKay, C, Cheasty, A, McArthur, K, Stanway, E, Leach, JD, Jackstadt, R, Waldron, JA, Campbell, AD, Vlachogiannis, G, Valeri, N, Haigis, KM, Sonenberg, N, Proud, CG, Jones, NP, Swarbrick, ME, McKinnon, HJ, Faller, WJ, Le Quesne, J, Edwards, J, Willis, AE, Bushell, M, Sansom, OJ |
| Contributors: | Valeri, Nicola |
| Publisher Information: | AMER ASSOC CANCER RESEARCH |
| Publication Year: | 2021 |
| Collection: | The Institute of Cancer Research (ICR): Publications Repository |
| Description: | KRAS-mutant colorectal cancers are resistant to therapeutics, presenting a significant problem for ∼40% of cases. Rapalogs, which inhibit mTORC1 and thus protein synthesis, are significantly less potent in KRAS-mutant colorectal cancer. Using Kras-mutant mouse models and mouse- and patient-derived organoids, we demonstrate that KRAS with G12D mutation fundamentally rewires translation to increase both bulk and mRNA-specific translation initiation. This occurs via the MNK/eIF4E pathway culminating in sustained expression of c-MYC. By genetic and small-molecule targeting of this pathway, we acutely sensitize KRASG12D models to rapamycin via suppression of c-MYC. We show that 45% of colorectal cancers have high signaling through mTORC1 and the MNKs, with this signature correlating with a 3.5-year shorter cancer-specific survival in a subset of patients. This work provides a c-MYC-dependent cotargeting strategy with remarkable potency in multiple Kras-mutant mouse models and metastatic human organoids and identifies a patient population that may benefit from its clinical application. SIGNIFICANCE: KRAS mutation and elevated c-MYC are widespread in many tumors but remain predominantly untargetable. We find that mutant KRAS modulates translation, culminating in increased expression of c-MYC. We describe an effective strategy targeting mTORC1 and MNK in KRAS-mutant mouse and human models, pathways that are also commonly co-upregulated in colorectal cancer.This article is highlighted in the In This Issue feature, p. 995. |
| Document Type: | article in journal/newspaper |
| File Description: | Print-Electronic; application/pdf |
| Language: | English |
| ISSN: | 2159-8290 2159-8274 |
| Relation: | Cancer discovery, 2020; https://repository.icr.ac.uk/handle/internal/4389 |
| Availability: | https://repository.icr.ac.uk/handle/internal/4389 |
| Rights: | https://creativecommons.org/licenses/by/4.0 |
| Accession Number: | edsbas.74393C20 |
| Database: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://repository.icr.ac.uk/handle/internal/4389# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.74393C20 RelevancyScore: 906 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 906.347900390625 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Knight%2C+JRP%22">Knight, JRP</searchLink><br /><searchLink fieldCode="AR" term="%22Alexandrou%2C+C%22">Alexandrou, C</searchLink><br /><searchLink fieldCode="AR" term="%22Skalka%2C+GL%22">Skalka, GL</searchLink><br /><searchLink fieldCode="AR" term="%22Vlahov%2C+N%22">Vlahov, N</searchLink><br /><searchLink fieldCode="AR" term="%22Pennel%2C+K%22">Pennel, K</searchLink><br /><searchLink fieldCode="AR" term="%22Officer%2C+L%22">Officer, L</searchLink><br /><searchLink fieldCode="AR" term="%22Teodosio%2C+A%22">Teodosio, A</searchLink><br /><searchLink fieldCode="AR" term="%22Kanellos%2C+G%22">Kanellos, G</searchLink><br /><searchLink fieldCode="AR" term="%22Gay%2C+DM%22">Gay, DM</searchLink><br /><searchLink fieldCode="AR" term="%22May-Wilson%2C+S%22">May-Wilson, S</searchLink><br /><searchLink fieldCode="AR" term="%22Smith%2C+EM%22">Smith, EM</searchLink><br /><searchLink fieldCode="AR" term="%22Najumudeen%2C+AK%22">Najumudeen, AK</searchLink><br /><searchLink fieldCode="AR" term="%22Gilroy%2C+K%22">Gilroy, K</searchLink><br /><searchLink fieldCode="AR" term="%22Ridgway%2C+RA%22">Ridgway, RA</searchLink><br /><searchLink fieldCode="AR" term="%22Flanagan%2C+DJ%22">Flanagan, DJ</searchLink><br /><searchLink fieldCode="AR" term="%22Smith%2C+RCL%22">Smith, RCL</searchLink><br /><searchLink fieldCode="AR" term="%22McDonald%2C+L%22">McDonald, L</searchLink><br /><searchLink fieldCode="AR" term="%22MacKay%2C+C%22">MacKay, C</searchLink><br /><searchLink fieldCode="AR" term="%22Cheasty%2C+A%22">Cheasty, A</searchLink><br /><searchLink fieldCode="AR" term="%22McArthur%2C+K%22">McArthur, K</searchLink><br /><searchLink fieldCode="AR" term="%22Stanway%2C+E%22">Stanway, E</searchLink><br /><searchLink fieldCode="AR" term="%22Leach%2C+JD%22">Leach, JD</searchLink><br /><searchLink fieldCode="AR" term="%22Jackstadt%2C+R%22">Jackstadt, R</searchLink><br /><searchLink fieldCode="AR" term="%22Waldron%2C+JA%22">Waldron, JA</searchLink><br /><searchLink fieldCode="AR" term="%22Campbell%2C+AD%22">Campbell, AD</searchLink><br /><searchLink fieldCode="AR" term="%22Vlachogiannis%2C+G%22">Vlachogiannis, G</searchLink><br /><searchLink fieldCode="AR" term="%22Valeri%2C+N%22">Valeri, N</searchLink><br /><searchLink fieldCode="AR" term="%22Haigis%2C+KM%22">Haigis, KM</searchLink><br /><searchLink fieldCode="AR" term="%22Sonenberg%2C+N%22">Sonenberg, N</searchLink><br /><searchLink fieldCode="AR" term="%22Proud%2C+CG%22">Proud, CG</searchLink><br /><searchLink fieldCode="AR" term="%22Jones%2C+NP%22">Jones, NP</searchLink><br /><searchLink fieldCode="AR" term="%22Swarbrick%2C+ME%22">Swarbrick, ME</searchLink><br /><searchLink fieldCode="AR" term="%22McKinnon%2C+HJ%22">McKinnon, HJ</searchLink><br /><searchLink fieldCode="AR" term="%22Faller%2C+WJ%22">Faller, WJ</searchLink><br /><searchLink fieldCode="AR" term="%22Le+Quesne%2C+J%22">Le Quesne, J</searchLink><br /><searchLink fieldCode="AR" term="%22Edwards%2C+J%22">Edwards, J</searchLink><br /><searchLink fieldCode="AR" term="%22Willis%2C+AE%22">Willis, AE</searchLink><br /><searchLink fieldCode="AR" term="%22Bushell%2C+M%22">Bushell, M</searchLink><br /><searchLink fieldCode="AR" term="%22Sansom%2C+OJ%22">Sansom, OJ</searchLink> – Name: Author Label: Contributors Group: Au Data: Valeri, Nicola – Name: Publisher Label: Publisher Information Group: PubInfo Data: AMER ASSOC CANCER RESEARCH – Name: DatePubCY Label: Publication Year Group: Date Data: 2021 – Name: Subset Label: Collection Group: HoldingsInfo Data: The Institute of Cancer Research (ICR): Publications Repository – Name: Abstract Label: Description Group: Ab Data: KRAS-mutant colorectal cancers are resistant to therapeutics, presenting a significant problem for ∼40% of cases. Rapalogs, which inhibit mTORC1 and thus protein synthesis, are significantly less potent in KRAS-mutant colorectal cancer. Using Kras-mutant mouse models and mouse- and patient-derived organoids, we demonstrate that KRAS with G12D mutation fundamentally rewires translation to increase both bulk and mRNA-specific translation initiation. This occurs via the MNK/eIF4E pathway culminating in sustained expression of c-MYC. By genetic and small-molecule targeting of this pathway, we acutely sensitize KRASG12D models to rapamycin via suppression of c-MYC. We show that 45% of colorectal cancers have high signaling through mTORC1 and the MNKs, with this signature correlating with a 3.5-year shorter cancer-specific survival in a subset of patients. This work provides a c-MYC-dependent cotargeting strategy with remarkable potency in multiple Kras-mutant mouse models and metastatic human organoids and identifies a patient population that may benefit from its clinical application. SIGNIFICANCE: KRAS mutation and elevated c-MYC are widespread in many tumors but remain predominantly untargetable. We find that mutant KRAS modulates translation, culminating in increased expression of c-MYC. We describe an effective strategy targeting mTORC1 and MNK in KRAS-mutant mouse and human models, pathways that are also commonly co-upregulated in colorectal cancer.This article is highlighted in the In This Issue feature, p. 995. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Format Label: File Description Group: SrcInfo Data: Print-Electronic; application/pdf – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2159-8290<br />2159-8274 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: Cancer discovery, 2020; https://repository.icr.ac.uk/handle/internal/4389 – Name: URL Label: Availability Group: URL Data: https://repository.icr.ac.uk/handle/internal/4389 – Name: Copyright Label: Rights Group: Cpyrght Data: https://creativecommons.org/licenses/by/4.0 – Name: AN Label: Accession Number Group: ID Data: edsbas.74393C20 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.74393C20 |
| RecordInfo | BibRecord: BibEntity: Languages: – Text: English Titles: – TitleFull: MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Knight, JRP – PersonEntity: Name: NameFull: Alexandrou, C – PersonEntity: Name: NameFull: Skalka, GL – PersonEntity: Name: NameFull: Vlahov, N – PersonEntity: Name: NameFull: Pennel, K – PersonEntity: Name: NameFull: Officer, L – PersonEntity: Name: NameFull: Teodosio, A – PersonEntity: Name: NameFull: Kanellos, G – PersonEntity: Name: NameFull: Gay, DM – PersonEntity: Name: NameFull: May-Wilson, S – PersonEntity: Name: NameFull: Smith, EM – PersonEntity: Name: NameFull: Najumudeen, AK – PersonEntity: Name: NameFull: Gilroy, K – PersonEntity: Name: NameFull: Ridgway, RA – PersonEntity: Name: NameFull: Flanagan, DJ – PersonEntity: Name: NameFull: Smith, RCL – PersonEntity: Name: NameFull: McDonald, L – PersonEntity: Name: NameFull: MacKay, C – PersonEntity: Name: NameFull: Cheasty, A – PersonEntity: Name: NameFull: McArthur, K – PersonEntity: Name: NameFull: Stanway, E – PersonEntity: Name: NameFull: Leach, JD – PersonEntity: Name: NameFull: Jackstadt, R – PersonEntity: Name: NameFull: Waldron, JA – PersonEntity: Name: NameFull: Campbell, AD – PersonEntity: Name: NameFull: Vlachogiannis, G – PersonEntity: Name: NameFull: Valeri, N – PersonEntity: Name: NameFull: Haigis, KM – PersonEntity: Name: NameFull: Sonenberg, N – PersonEntity: Name: NameFull: Proud, CG – PersonEntity: Name: NameFull: Jones, NP – PersonEntity: Name: NameFull: Swarbrick, ME – PersonEntity: Name: NameFull: McKinnon, HJ – PersonEntity: Name: NameFull: Faller, WJ – PersonEntity: Name: NameFull: Le Quesne, J – PersonEntity: Name: NameFull: Edwards, J – PersonEntity: Name: NameFull: Willis, AE – PersonEntity: Name: NameFull: Bushell, M – PersonEntity: Name: NameFull: Sansom, OJ – PersonEntity: Name: NameFull: Valeri, Nicola IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 21598290 – Type: issn-print Value: 21598274 – Type: issn-locals Value: edsbas – Type: issn-locals Value: edsbas.oa |
| ResultId | 1 |